Ketoconazol Ratiopharm

Ketoconazole, the active ingredient in Ketoconazole Ratiopharm, is an imidazole antifungal presented as a topical formulation for skin use. It is employed to treat fungal skin infections such as dermatophytosis, seborrheic dermatitis and tinea versicolor in adult patients.

GNH USA supplies Ketoconazole Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory documentation for importers.

Ketoconazole is used to treat fungal skin conditions by targeting the dermatophyte and yeast families.

Dermatophytosis: reduces fungal growth and clears skin lesions. Seborrheic dermatitis: alleviates scaling and erythema on scalp and face. Tinea versicolor: eliminates Malassezia overgrowth and restores normal pigmentation.

Topical ketoconazole may cause local skin reactions ranging from mild irritation to rare severe events.

Common Side Effects: - Skin irritation or burning sensation at the application site. - Itching or pruritus. - Redness or erythema. - Dryness or scaling of the treated area. - Mild contact dermatitis. - Transient stinging.

Serious or Rare Side Effects: - Severe allergic reaction (e.g., angioedema, anaphylaxis). - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Contact urticaria. - Photosensitivity leading to exaggerated sunburn. - Hepatotoxicity if systemic absorption occurs. - Severe dermatitis with blistering.

When using topical ketoconazole, certain precautions help minimize adverse reactions and ensure safe application.

Avoid application on broken or inflamed skin: may increase systemic absorption. Do not apply near eyes or mucous membranes: can cause irritation. Limit exposure to sunlight: product may increase photosensitivity. Discontinue use if severe irritation or allergic reaction occurs: seek medical advice. Store at room temperature: keep in original container, protect from moisture and light.

Ketoconazole can interact with other topical or systemic agents, affecting efficacy or safety.

Major Interactions (Avoid): - Concurrent use with other azole antifungals: may increase local irritation. - Systemic ketoconazole therapy: may raise systemic exposure and risk of hepatotoxicity.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: may reduce antifungal effectiveness. - Phototoxic agents (e.g., retinoids): may heighten photosensitivity. - Alcohol‑based skin cleansers: may alter drug absorption.